Why was this compound abandoned ? Research/Science 2/27/2026
KY19382, a promising compound for hair loss, is not widely discussed or used. One user is currently testing it and plans to share results in a few weeks.
View this post in the Community →
Similar Community Posts Join
5 / 1000+ resultscommunity User experiencing hair loss on dutasteride; others suggest shedding is normal and to track progress with pictures. Some mention using RU58841 for improvement.
User experiencing hair loss on dutasteride; others suggest shedding is normal and to track progress with pictures. Some mention using RU58841 for improvement.
community The user is experiencing significant hair loss after switching from finasteride to dutasteride for five months. Suggestions include that the hair loss might be a normal shedding phase, with some recommending continuing the treatment for up to 24 months or considering alternatives like RU58841.
The user is experiencing significant hair loss after switching from finasteride to dutasteride for five months. Suggestions include that the hair loss might be a normal shedding phase, with some recommending continuing the treatment for up to 24 months or considering alternatives like RU58841.
community A user who underwent a hair transplant in Istanbul to reduce balding, and the discussion of various treatments such as finasteride and growth hormone for preventing further hair loss.
A user who underwent a hair transplant in Istanbul to reduce balding, and the discussion of various treatments such as finasteride and growth hormone for preventing further hair loss.
community The conversation discusses disappointment with the hair loss treatment KX-826 but notes that the company Kintor is still focused on developing and commercializing it, as stated in their 2023 annual report. The user questions the effectiveness of KX-826 in comparison to minoxidil's role in improving hair thickness and appearance.
The conversation discusses disappointment with the hair loss treatment KX-826 but notes that the company Kintor is still focused on developing and commercializing it, as stated in their 2023 annual report. The user questions the effectiveness of KX-826 in comparison to minoxidil's role in improving hair thickness and appearance.
community People are not using RU58841 for hair loss because it's not FDA approved, lacks long-term safety data, and is difficult to obtain and verify. They prefer FDA-approved treatments like minoxidil, finasteride, ketoconazole shampoo, and microneedling.
People are not using RU58841 for hair loss because it's not FDA approved, lacks long-term safety data, and is difficult to obtain and verify. They prefer FDA-approved treatments like minoxidil, finasteride, ketoconazole shampoo, and microneedling.
Related Research
6 / 1000+ results
research Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.
Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.
research Honokiol might help reduce male skin aging by maintaining testosterone levels.
Honokiol might help reduce male skin aging by maintaining testosterone levels.
research Harriet E. Wilson had a challenging career as a spiritualist in Boston, facing competition and possible racism.
Harriet E. Wilson had a challenging career as a spiritualist in Boston, facing competition and possible racism.
research Both mouse and rat models are effective for testing alopecia areata treatments.
Both mouse and rat models are effective for testing alopecia areata treatments.
research Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.
Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.
research Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.
Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.